Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, but showed signs of recovery in the second quarter, particularly in military and consumer electronics sectors, leading to a maintained "buy" rating [1][4]. Financial Performance - In H1 2025, the company achieved revenue of 1.07 billion yuan, down 17.82% year-on-year, and a net profit of 201 million yuan, down 17.66% year-on-year [1]. - Q2 2025 revenue was 720 million yuan, up 18.23% year-on-year and up 105.84% quarter-on-quarter, with net profit of 144 million yuan, up 16.20% year-on-year and up 150.01% quarter-on-quarter [1]. Business Segments - The T/R component and RF module business generated revenue of 944 million yuan in H1 2025, down 19.27% year-on-year, while the RF chip business saw revenue of 91 million yuan, up 3.72% year-on-year [2]. - The company is actively expanding T/R component applications in low Earth orbit satellites and commercial aerospace, with several products already delivered to customers [2]. Profitability and Cost Management - The overall gross margin for H1 2025 was 39.11%, an increase of 3.97 percentage points year-on-year, attributed to a higher proportion of self-developed chips and effective cost control [3]. - The company’s R&D expenditure reached 130 million yuan, focusing on new products in T/R components and mobile communication RF chips [3]. Profit Forecast and Valuation - Projected net profits for 2025-2027 are 529 million yuan, 670 million yuan, and 821 million yuan, respectively, with a target price of 69.24 yuan per share based on a 78x PE ratio for 2025 [4].

Core Viewpoint - The company has shown signs of recovery in revenue and net profit in Q2 2025, with a focus on improving management and operational efficiency [2][4]. Financial Performance - In Q2 2025, the company achieved revenue of 720 million yuan, a year-on-year increase of 18.23%, and a net profit attributable to shareholders of 144 million yuan, up 16.20% year-on-year [2]. - For the first half of 2025, the company's T/R components and RF module business generated revenue of 944 million yuan, a decrease of 19.27% year-on-year, while the RF chip business saw revenue of 91 million yuan, an increase of 3.72% year-on-year [2]. - The company's total liabilities decreased by 19.25% year-on-year to 1.472 billion yuan, while cash and cash equivalents fell by 32.99% to 1.867 billion yuan [1]. Product Development and Market Position - The company is a leading domestic provider of active phased array T/R components, with increasing demand in radar communication technology [3]. - The company is expanding its application fields for T/R components into low Earth orbit satellites and commercial aerospace, with multiple products already delivered to customers [3]. - In the RF integrated circuit sector, the company has achieved large-scale supply of RF integrated circuits and modules for domestic 4G and 5G mobile communication, with potential growth in 5G-A and 6G technologies [3]. Investment Outlook - The company is projected to have EPS of 0.96, 1.22, and 1.56 for 2025-2027, with corresponding PE ratios of 67.5, 53.1, and 41.4 based on the closing price of 64.72 yuan on August 28 [4].

Investment Rating - The report maintains a "Recommended" rating for the company [3][6]. Core Views - The company reported a revenue of 1.07 billion yuan in 1H25, a year-over-year decrease of 17.8%, while the net profit attributable to the parent company was 200 million yuan, also down 17.7% year-over-year. The performance met expectations [1]. - In 2Q25, the company achieved a revenue of 720 million yuan, reflecting a year-over-year growth of 18.2%, and a net profit of 140 million yuan, up 16.2% year-over-year. The gross margin for 1H25 improved by 4.0 percentage points to 39.1% [1][2]. - The company is actively expanding its T/R component applications in low-orbit satellites and commercial aerospace, with multiple products already delivered to customers [2][3]. Summary by Sections Financial Performance - 1H25 revenue was 1.07 billion yuan, down 17.8% year-over-year; net profit was 200 million yuan, down 17.7% year-over-year; the performance was in line with expectations [1]. - 2Q25 revenue was 720 million yuan, up 18.2% year-over-year; net profit was 140 million yuan, up 16.2% year-over-year; gross margin improved to 39.1% [1][2]. Product Segmentation - T/R components and RF modules generated 760 million yuan in revenue, down 25.8% year-over-year, accounting for 71% of total revenue, with a gross margin increase of 7.6 percentage points to 44.1% [2]. - The company is developing new RF switch and antenna tuning products for mobile communication terminals, with several new RF switches in mass production [2]. Cost and Inventory Management - The period expense ratio increased by 0.2 percentage points to 18.3% in 1H25, with sales and management expenses rising [3]. - As of the end of 2Q25, accounts receivable and notes totaled 3.27 billion yuan, down 2.3% from the beginning of the year, while inventory increased by 29.8% to 330 million yuan [3]. Investment Outlook - The company is a leading provider of active phased array T/R components and RF integrated circuit products in China. The forecasted net profits for 2025, 2026, and 2027 are 504 million yuan, 679 million yuan, and 883 million yuan, respectively [3][5].

Group 1 - The core viewpoint of the news is that Yongjin Investment has conducted research on Guobo Electronics, focusing on various aspects such as gross margin improvement, revenue changes, inventory management, and strategic development in response to industry trends [1] - Guobo Electronics has detailed its strategies for enhancing gross margin through cost control and product structure adjustments, despite revenue fluctuations due to macroeconomic factors [1] - The company reported a normal increase in inventory for production reserves in the first quarter, indicating stable production levels [1] - T/R component products are characterized by customization, with revenue recognition based on customer acceptance [1] - Guobo Electronics is actively participating in key projects and maintaining stable prices for mainstream products, with good capacity utilization [1] - The company is strategically expanding into satellite and low-altitude fields, with RF chips already applied in terminal products such as drones, addressing the demands of next-generation mobile communication technologies like 5G-A and 6G [1] - Future plans include extending into antenna array microsystems and deepening involvement in active phased array radar and RF front-end for 5G-A/6G communication base stations, promoting high-quality development [1]

Group 1: Guobo Electronics - Guobo Electronics has improved its gross margin through cost control and product structure adjustments, despite revenue fluctuations due to macroeconomic factors [1] - The company reported a normal increase in inventory as part of production reserves, with stable prices for mainstream products and good capacity utilization [1] - Guobo is actively participating in key projects and is expanding into satellite and low-altitude fields, with RF chips already applied in drone products to meet the demands of next-generation mobile communication technologies [1] Group 2: Lege Co., Ltd. - In 2024, Lege Co., Ltd. faced a challenging environment with a revenue growth of 45.33% but a net profit decline of 46.99%, primarily due to reduced non-recurring income and increased R&D investment [2] - The company has expanded its overseas warehouse operations to 662,100 square meters, serving 1,175 enterprises and shipping over 11 million items, with a capacity utilization rate of 60%-70% [2] - Lege plans to maintain steady progress in 2025, focusing on smart home and overseas warehouse dual main businesses while enhancing brand building and talent optimization [2] Group 3: Baike Biotech - Baike Biotech experienced significant declines in performance in 2024 and the first quarter of 2025, with decreases of 32.64% and 39.96% respectively, mainly due to the impact on shingles vaccine sales [3] - The company aims to enhance market awareness of the shingles vaccine and solidify its position in the chickenpox vaccine market while expanding into international markets [3] - Baike anticipates an increase in R&D investment and sales expense ratios in 2025, followed by a gradual decrease [3] Group 4: Mona Lisa - Mona Lisa is facing multiple challenges in 2024 due to changes in trade environments and real estate adjustments, leading to a 16.34% decline in sales volume and revenue [4] - The company has seen a 20.72% decrease in operating costs, primarily due to lower direct material and fuel costs, and has implemented cost reduction and efficiency measures [4] - Looking ahead to 2025, the industry faces challenges from weakened demand, but urbanization and stock housing renovations present new opportunities [4]